BAY 73-1449

Research use only, not for human use.

BAY 73-1449 is a selective and potent antagonist of the prostacyclin receptor(IC50<0.1 nM).

BAY 73-1449 is a selective and potent antagonist of the prostacyclin receptor(IC50<0.1 nM).(In Vivo):In male Wistar rats, BAY 73-1449 (0.1-1 mg/kg; i.v.) significantly reduced splenic shunt vessel outflow without affecting mesenteric inflow. BAY 73-1449 (1-5 mg/kg; s.c.) has no effects on portal pressures and the degree of porto-systemic shunting in rats.

——

BAY 73-1449 (0.1-1 mg/kg; i.v.) does not significantly reduce mesenteric inflow, but significantly reduces splenic shunt vessel outflow in rats.BAY 73-1449 (1-5 mg/kg, s.c. once daily for 7 d) has no effects on the degree of porto-systemic shunting in rats.BAY 73-1449 (1 mg/kg, s.c. once daily for 7 d), has no effects on portal pressures in rats. Animal Model:Male Wistar rats (250-350 g) are ligated portal veinDosage:0.1, 1 mg/kg.Administration:A single i.v.Result:Significantly reduced shunt flow without affecting mesenteric flow.

BAY73-1449 | BAY 73-1449

Others

Other Targets

RhoA| Lbc

——

——

693790-96-4

425.488

C26H23N3O3

>98% (HPLC)

In Vitro:?DMSO : 250 mg/mL (587.57 mM)

OC(=O)[C@H](Cc1ccccc1)Nc1cc(ncn1)-c1ccc(OCc2ccccc2)cc1

——

(-20℃)

With Ice Pack

≥ 2 years